Pharmanovia to acquire 11 central nervous system brands from Sanofi.

Pharmanovia, a global pharmaceutical company, agreed to acquire 11 central nervous system brands from Sanofi, a global healthcare company. Financial terms were not disclosed. “Sanofi’s decision to divest this established CNS portfolio, with leading brands such as Frisium and Gardena, to Pharmanovia is recognition of our neurology expertise, our capabilities in lifecycle management and reputation of being a trusted divestment partner. We’re excited to use this knowledge and our global platform to ensure these important medicines not only continue to be available to the millions of patients who need them, but - through our lifecycle management - continue to evolve to meet patient needs," James Burt, Pharmanovia CEO.